DentScribe.ai improves dental practices with GPS
This new feature of the AI-driven dental software suite provides a comprehensive view of patient care, actionable insights, and production opportunities, all derived from AI-generated SOAP notes.
DentScribe GPS utilises real-time AI analysis of dentists' professional assessments, rather than relying on static diagnostic imaging.
This approach ensures accurate identification of high-value production opportunities, everyday operational priorities, and urgent patient care needs, directly impacting both patient outcomes and practice profitability.
The system's tablet-first interface is designed for ease of use during morning huddles and everyday planning sessions.
Dental teams are offered real-time access to planned production, critical alerts, patient follow-ups, and practice performance metrics.
The visual categorisation of opportunities by urgency and financial value enables teams to prioritise tasks effectively.
DentScribe.ai founder and CEO Dr Vinni Singh said: "DentScribe GPS changes everything about our morning huddles. We now start each day knowing exactly where to focus our efforts to maximise both patient care and practice profitability.
'By harnessing AI-driven insights directly from our SOAP notes, we are identifying care opportunities and revenue streams that diagnostic tools alone simply cannot see."
Early adopters of DentScribe GPS have reported improvements in their practices.
On average, they have identified 51 high-value production opportunities per day and detected 28 urgent care interventions.
Additionally, efficiency scores have exceeded 99%, indicating improved team productivity and optimal resource allocation.
The system's motivational gamification features include production streaks of 47 days.
Included in the DentScribe GPS is the Daily Brief, a DentScribe GPS Intelligence offering a concise summary of the day's critical priorities and strategies for revenue optimisation.
This allows dental teams to rapidly assimilate important information and make informed decisions at the beginning of each day.
"DentScribe.ai improves dental practices with GPS" was originally created and published by Hospital Management, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
Interview: Pearson UK CEO on AI driven edtech transformation
A Pearson veteran of 25 years, Sharon Hague has an extensive background in education including eight years of secondary school teaching. From the coal face of education to her strategic leadership role within Pearson, Hague's guiding principal has always been harnessing the transformational power of education. In this vein, she believes that AI is once in a generation opportunity to transform education at all ages and stages. According to Hague, AI's power lies in its potential to 'amplify the teacher, not to replace the teacher, but to reduce the administrative burden, manual data collection, and really support the teacher in concentrating on what they do best; interacting with young people, supporting, motivating and helping them with their learning.' The Covid-19 pandemic was an inflection point—borne of necessity—for the global edtech market when teaching quickly pivoted online. Global edtech revenue in 2020 increased by some 23% to $158bn. And though the exceptionally strong growth rate did not hold, GlobalData expects the industry to grow at a compound annual growth rate of 9.8% between 2022 and 2030, reaching $535bn in 2030. Pearson is looking towards the next big technology driven market shift by developing a suite of AI enabled products. The multinational corporation, headquartered in the UK, was founded in 1856 and has undergone many iterations which included national and international subsidiaries in manufacturing, electricity, oil, coal, banking and financial services, publishing (periodicals and books), and aviation. In 1998, Pearson plc formed Pearson Education, and by 2016, education publishing and services had become the company's exclusive focus. Hague is also president of Pearson's English Language Learning (ELL) division which provides English language assessments and learning materials for English learners globally. The ELL business has launched a smart lesson generator which enables teachers to identify lesson priorities and create lesson content and activities. Aside from reducing the administrative burden for teaching staff, Hague notes that AI will unlock personalised learning in a way that has hitherto been unavailable without the physical presence of a teacher. She is excited about AI addressing individual student needs, particularly when access arrangements and accessibility issues are proving to be a barrier, ". 'It will enable children with different types of learning needs to be able to access more learning and "to create a better experience'. Pearson is also developing an AI driven GCSE revision tool which will allow students to receive feedback and suggestions outside the classroom in the absence of a teacher. 'The child will write a response, and then the app gives feedback on what they've covered, as well as things to think about, and links to further practice,' explains Hague. The tool is being developed in collaboration with teachers and, though still in development, the feedback is reportedly positive. The company is developing a similar product for use in higher education to deliver instantaneous feedback or suggestions when a tutor is unavailable. Though adoption is not guaranteed, Pearson's own research published in Dec 2024, found that some 58% of US Higher Education students say they are using generative AI for academic purposes (up 8% percentage points from Spring 2024). AI hallucinations and mishaps make striking headlines and carry reputational risk for any business launching AI tools. So, what of accuracy? Pearson's background in pedagogy and learning science, combined with the high-quality and trusted content means that the company is well placed to deliver products in an industry that requires a high level of accuracy, says Hague. 'I think we are drawing on content that we know is high quality, is proprietary content, so anyone using the tool can be assured it's accurate,' she says. When pressed on the potential for hallucinations in feedback offered to students, Hague reiterates that the tools in development are not being designed to replace teachers, but only to support existing teaching processes. 'We're not letting it [LLM] go out into the wild internet and just put anything in. With both our revision tool, and our smart lesson generator, we thought really carefully about how it's designed, because we're conscious that, particularly when young people are preparing for GCSE where there are certain requirements, that it's not just pulling from anywhere." Looking forward, Hague envisions the technology component in education to increase with use cases including anything from teaching support to a student's experience of examinations. 'At the moment, if you take a colour coded paper-based examination, you could do that much more seamlessly on a screen. The child could actually personalise how they're viewing the exam paper, so that it would meet their needs,' says Hague. In the same way, speech recognition could enable many different tools for children with different accessibility requirements. 'There are lots of opportunities within school-based education and higher education,' says Hague. As AI infiltrates traditional learning processes, concerns are growing around the erosion of the human capacity for critical thinking. Pearson conducted analyses of over 128,000 student queries to Pearson's AI study tools in Campbell Biology, the most popular title used in introductory biology courses. The company categorised student inputs using Bloom's Taxonomy, a framework used to understand the cognitive complexity of students' questions and found that one-third of student queries were at higher levels of cognitive complexity, with 20% of student inputs reflecting the critical thinking skills essential for deeper learning. Pearson is also working with enterprise clients in upskilling and training staff around how they leverage AI. 'There's an increasing skills gap that we're all aware of,' notes Hague. Pearson's Fathom tool analyses automation opportunities within the enterprise. The tool can be used for re-skilling purposes, for talent planning and assessing these skills gaps. This is particularly relevant to the UK market, says Hague, as UK companies spend 50% less on continuous training than their European counterparts. 'There's some really great opportunities around continuous review people's work whilst they're working, by giving them feedback and address skills gaps to improve people's performance as they're working. And technology enables you to do that, rather than more traditional routes, where you might have a training for a couple of days,' says Hague. Ongoing credentialing is another AI application for the enterprise market. Pearson's certification system Credly is digital badging that recognises workplace achievement and continuous learning. This employee certification earned as they learn while in the workflow is something they can take with them into their career. Hague's advice to businesses looking at implementing AI tools is to analyse where the opportunities lie for automation, develop skills and re-skill within the workforce for future needs. 'Hiring is not going to be the way to solve everything you've really got to focus on training and re-skilling at the same time,' she says. And as the edtech landscape becomes increasingly AI driven, the need for companies to address their skill requirements only grows more urgent. "Interview: Pearson UK CEO on AI driven edtech transformation" was originally created and published by Verdict, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 hours ago
- Yahoo
Trump's 200% tariff threat could send shockwaves through pharma supply chains
US President Donald Trump's 200% tariff threat on the pharmaceutical industry is a "shock" that will reverberate through global supply chains. Speaking at the White House on 8 July, Trump said: 'We'll be announcing something very soon on pharmaceuticals. We're going to give people about a year, year and a half to come in, and after that they're going to be tariffed if they have to bring the pharmaceuticals into the country at a very high rate, like 200%.' This is significantly higher than the 25% tariff threatened by the US President in March 2025. When 10% tariffs came into effect for several countries, pharmaceuticals were given a temporary exemption, but both Trump and US Commerce Secretary Howard Lutnick continued to suggest pharmaceutical tariffs would be implemented within months. Cyrus Fan, research analyst in the GlobalData life sciences team, said that the industry is trying to warn Trump that these tariffs may be counterproductive for the US healthcare system, with moves to onshoring set to take years, not months. Fan said: 'Trump has repeatedly encouraged the building of new manufacturing sites for drugmakers. In May, Trump signed an executive order to help streamline pharma companies to build new US drug manufacturing production sites. "Moving pharma manufacturing domestically takes years, far longer than the grace period Trump is proposing in his recent cabinet meeting. Multiple pharma companies have pledged billions of dollars to increase their US manufacturing presence since Trump started his second term in office. However, the industry continues to warn Trump that tariffs on medicines would be counterproductive and could increase the costs of medicines.' Chartered Institute of Export & International Trade's director general Marco Forgione said: 'This kind of tariff shock, especially at a proposed rate of 200%, would reverberate through global pharmaceutical supply chains. UK exporters are deeply integrated into US healthcare delivery, from innovative treatments to specialist manufacturing inputs. Any move to isolate or penalise those partnerships risks triggering a counterproductive scramble to localise production, which would raise costs and delay access to lifesaving treatments on both sides of the Atlantic." 'Pharmaceutical supply chains are also incredibly complex, and any tariff could carry real global consequences. UK firms exporting to the US may find themselves caught in the crossfire, particularly SMEs and contract manufacturers who lack the leverage or flexibility to shift production overnight. We need coordinated diplomacy and sector engagement to avoid a new tariff arms race in essential goods." Despite the announcement on 8 July, most pharma stocks remained stable, with some slight dips in major companies with global manufacturing capabilities. Eli Lilly's stock dropped 2.24% from $791.64 pre-announcement to $773.02 post-announcement, likely due to Lilly's manufacturing capabilities in Ireland. The pharma giant's stock did recover slightly, closing at $777.66. Ireland hosts 12 of the largest global drug manufacturers, many of which produce medicines or active ingredients for the American market. Earlier this year, Irish medical and pharmaceutical exports to the US saw a significant surge, with a year-on-year increase above 450% in February 2025, according to data released on 15 April and reported by Reuters. In February, Ireland's Central Statistics Office stated that these product exports to the US reached €10.5bn ($11.8bn), up from €1.9bn in the same month of 2024. This followed a substantial increase in January, when exports rose 130% to €9.4bn. In addition to Ireland, India and China are also major suppliers of active pharmaceutical ingredients to the US, with major contract manufacturing organisations (CMOs) such as WuXi Biologics that have large plants in China. To try and curb the impact of incoming pharma tariffs, several pharmaceutical companies have already made announcements for investment into manufacturing facilities in the US. Eli Lilly will be investing an extra $27bn into US-based sites, with Novartis, Sanofi, and others having made similar moves to onshore manufacturing in the country. Navigate the shifting tariff landscape with real-time data and market-leading analysis. Request a free demo for GlobalData's Strategic Intelligence . "Trump's 200% tariff threat could send shockwaves through pharma supply chains" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15 hours ago
- Yahoo
Major global events drive hotel pricing shifts in 2025
Global hotel pricing has seen significant shifts in 2025, largely influenced by a packed calendar of major events including the Summer Olympics, Eurovision, and Taylor Swift's ongoing Eras Tour. According to the latest Lighthouse report, these high-profile occasions are reshaping revenue strategies and booking behaviours across key markets. The report highlights a strong correlation between major entertainment and sporting events and hotel price surges. Paris, host of this year's Olympics, recorded average daily rates (ADR) exceeding €700 for peak dates, a sharp rise from the €200–€300 average in the weeks surrounding the games. Similar pricing spikes were observed in Stockholm during Eurovision and in European cities such as Dublin, Zurich and Milan when hosting Taylor Swift's concerts. These temporary demand boosts are not limited to flagship cities. Secondary markets like Gelsenkirchen in Germany and Tullahoma in Tennessee have also experienced substantial rate increases, driven by football tournaments and concert tourism. ADRs in Gelsenkirchen nearly doubled during UEFA EURO 2024, despite the city's relatively modest hotel stock. Hoteliers are employing a range of dynamic pricing tactics to optimise revenue. The report notes that hotels are adjusting minimum stay requirements, offering bundled experiences, and using data to forecast booking windows. For instance, demand for city centre hotels typically surges 10 to 14 days before an event, prompting last-minute pricing changes. This short booking window reflects the growing trend of travellers making decisions closer to their desired stay dates. Hotel operators are also aligning rate structures with check-in and event times, ensuring prices match peaks in guest arrivals. The Eras Tour, in particular, has prompted properties to refine weekend pricing models, as cities like Warsaw and Edinburgh have seen sold-out weekends months in advance. The report also points to a rise in extended stays surrounding major events, particularly in summer destinations. This pattern has been influenced by increasing airline ticket prices, leading travellers to extend trips to make their journeys more worthwhile. Properties in southern European cities such as Lisbon and Barcelona are adapting to this by offering packages tailored to longer stays, especially during high-demand periods. Event-driven demand continues to shape global hotel booking patterns, with operators under pressure to remain agile. While headline acts and global sporting fixtures may dominate pricing headlines, the broader trend underscores the need for data-informed strategies across the hospitality sector. "Major global events drive hotel pricing shifts in 2025" was originally created and published by Hotel Management Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
